The Board of Directors of CanSino Biologics Inc. announced that on February 23, 2024, at the first meeting of the third session of the Board of Directors, the Board of Directors has resolved and approved the elections relating to the Board of Directors and Board committees, all with effect from February 23, 2024. On the same date, at the first meeting of the third session of the Board of Supervisors, the Board of Supervisors has resolved and approved the election relating to the Board of Supervisors, with effect from February 23, 2024. At the first meeting of the third session of the Board of Directors, Dr. Xuefeng YU was elected as the chairman of the third session of the Board of Directors.

At the first meeting of the third session of the Board of Directors, the Board of Directors has resolved and approved the elections of the various members to the three Board committees of the third session of the Board of Directors as follow: Audit Committee: Mr. Yiu Leung Andy CHEUNG (Chairman), Mr. Shuifa GUI, Mr. Jianzhong LIU. Remuneration and Assessment Committee: Mr. Shuifa GUI (Chairman), Mr. Yiu Leung Andy CHEUNG, Dr. Xuefeng YU. Nomination Committee: Mr. Jianzhong LIU (Chairman), Mr. Yiu Leung Andy CHEUNG, Mr. Shuifa GUI, Ms. Nisa Bernice Wing-Yu LEUNG, Dr. Xuefeng YU.

Each of the term of office of committee members in their respective Board committees will be effective from February 23, 2024 until the expiry of the term of the third session of the Board of Directors. On February 22, 2024, the Company has held an employee's representatives meeting to elect Ms. Yuan ZHOU ("Ms. ZHOU") as an employee representative Supervisor of the third session of the Board of Supervisors. Ms. ZHOU, female, born in 1988, Chinese nationality, with no permanent residency outside China, Master of Laws, worked as a legal assistant in Grandall Law Firm (Tianjin) from October 2012 to July 2016.

From August 2016 to April 2019, she worked as a legal manager in Herong Futures Co. Ltd. Since May 2019, she has served successively as legal manager, senior legal manager, deputy legal director of the legal department, and senior director of the legal and compliance department and internal audit department of the Company. She is currently serving as a supervisor in certain subsidiaries of the Company, namely CanSino Biology (Shanghai) Co.

Ltd., CanSino (Shanghai) Biotechnology Co. Ltd., CanSino (Shanghai) Biological Research and Development Co. Ltd., Kangbo (Tianjin) Pharmaceutical Technology Co.

Ltd. and Bomai (Tianjin) Venture Capital Management Co. Ltd. At the first meeting of the third session of the Board of Supervisors, Mr. Zhi XIAO was elected as the chairman of the third session of the Board of Supervisors.